📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2. (2013)

First Author: Gonzalez M

Attributed to: Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis - The International IBM Consortium Genetic Study funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jnnp-2013-305049

PubMed Identifier: 23729695

Publication URI: http://europepmc.org/abstract/MED/23729695

Type: Journal Article/Review

Volume: 84

Parent Publication: Journal of neurology, neurosurgery, and psychiatry

Issue: 11

ISSN: 0022-3050